Consortium-authored scientific activities are shared on this page.
Willett, C. (2013). Pathway-based Approaches to Safety Assessment: Development and Use. Presented at the IVTIP Spring 2013 Meeting ’2013: State of the art on alternatives from an industrial point of view: ready for regulation?’ May 15-16, 2013, Southampton, UK.
Willett, C. (2013). The Future of Endocrine Screening: An Animal Welfare Perspective. Presented at Lessons Learned, Challenges, and Opportunities: The US Endocrine Disruptor Screening Program, April 23-24, 2013, North Carolina Biotechnology Center, Research Triangle Park, North Carolina.
Willett, C. (2012). Evolving Approaches to AOP Development: Observations from MOA Frameworks to Systems Biology. Presented at the SEURAT-1 Workshop: Liver Toxicity Adverse Outcome Pathways, 25-26 October 2012, Ispra, Italy.
Willett, C. (2012). Tox21C: The AOP Approach Applied to REACH axlr8-progress-report-2012, in Alternative Testing Strategies: Progress Report 2012 & AXLR8-3 Workshop Report on a ‘Roadmap to Next Generation Safety Testing Under Horizon 2020,’ eds. Troy Seidle and Horst Spielmann, AXLR8 Consortium. (Also presented at the AXLR8 Workshop, 10 June 2012, Berlin Germany.)
Stephens, M.L., et al. (2012). Accelerating the Development of 21st-Century Toxicology: Outcome of a Human Toxicology Project Consortium Workshop. Toxicological Sciences 125(2): 327-334.